~~<i id='58BE002061'><strike id='58BE002061'><tt id='58BE002061'><pre id='58BE002061'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：entertainment 2025-09-29 18:48:38 Page View：911

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Racing yachts have close encounter with pod of orcas near Strait of Gibraltar
Next article： Guidelines to prevent youth baseball injuries need more muscle

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

Hearing on Medicare drug price negotiation gets unusually heated

AtaWednesdayhearing,OversightsubcommitteeChairMorganGriffith(R-Va.)mockedMedicaredrugpricenegotiatio

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Lasker Awards 2023: Winners in biomedical research

Thewinnersofthe2023LaskerAwardsdistinguishedthemselvesinareasincludingAI-enabledproteinmodeling.Wiki